| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |